ESH Video

#ESHCLL2024 SUBMIT YOUR ABSTRACT NOW: Deadline on January 2nd, 2024

December 07, 2023


3rd Translational Research Conference



March 8-10, 2024

Vienna, Austria





Extended deadline for abstract submission:
January 2nd, 2024 (23:59 CET)


Abstracts are eligible to be selected for an oral or a poster presentation.



About the Conference:

The 3rd ESH Tranlational Research Conference on CHRONIC LYMPHOCYTIC LEUKAEMIA is proposing a programme of leading-edge basic and clinical science where a panel of global experts in the field will provide numerous opportunities for formal and informal interactions to discuss the present and the future of CLL research. It is open to an international audience of biologists and clinicians, particularly welcoming those in-training.

This translational research conference will explore the most recent advances in the understanding of the pathogenesis and clinical management of the disease.  Open and spirited discussion on the most up-to-date information in the field is expected to understand how the many new biologic insights apply to the future of CLL.





• CLL disease progression
• Richters syndrome
• Biomarkers: where do we stand?
• Targeting the microenvironment in CLL
• What is the best time-limited therapy
• BTK inhibitors
• Small molecule resistance
• Next generation therapies
• The future: other targets


The programme will include:
Plenary Sessions - Simultaneous Meet the Experts Sessions - Brief Oral Communications
Mentored Poster Walk - Ample time for in-depth discussion.



For more information, click here!



With the support of*:

Major Conference Partner

*ESH conference programmes are developed in strict scientific independence
with no input from corporate sponsors.